Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling

Digestive Diseases and Sciences
S F MossP R Holt

Abstract

Colonic carcinogenesis is accompanied by progressive genetic changes and alterations in growth control. To examine whether abnormalities of apoptosis are involved in carcinogenesis, we examined epithelial apoptosis in formalin-fixed normal and neoplastic colon by terminal uridine deoxynucleotide nick end-labeling (TUNEL) histochemistry. In normal colon, resection margins, and hyperplastic polyps, TUNEL-positive cells comprised around 3% of total colonocytes, with over 85% of these cells located in surface epithelium between crypts. In adenomas, there were significantly fewer TUNEL-positive cells at the luminal surface than normal (1.82 +/- 0.51% of epithelial cells, compared with 12.1 +/- 2.3%, P < 0.05) and a trend to increased numbers at the crypt base (2.70 +/- 0.98% compared with 0.65 +/- 0.15%). Carcinomas contained fewer TUNEL-positive cells than normal (1.7 +/- 0.27%), and they are randomly distributed. Transitional mucosa had significantly more TUNEL-positive colonocytes than normal (11.0 +/- 3.0%, P < 0.005), both at the surface and crypt base. These results show that colonocyte apoptosis normally occurs mainly in luminal cells but that early during carcinogenesis the distribution and quantity of apoptotic cells changes.

References

Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Aug 9, 1991·Science·K W KinzlerD McKechnie
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D M HockenberyS J Korsmeyer
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Dec 23, 1994·Science·P Modrich
Dec 1, 1994·Cell and Tissue Research·M Kressel, P Groscurth
May 20, 1994·Cell·E Ruoslahti, J C Reed
Dec 10, 1993·Science·B RubinfeldP Polakis
Jan 1, 1994·The Journal of Cell Biology·J C Reed
Oct 1, 1993·Gastroenterology·K Croitoru, R H Riddell

❮ Previous
Next ❯

Citations

Jan 9, 2009·Apoptosis : an International Journal on Programmed Cell Death·Beata PajakArkadiusz Orzechowski
Dec 17, 2002·Critical Reviews in Oncology/hematology·J J KoornstraJ H Kleibeuker
Apr 12, 2000·Journal of Gastroenterology and Hepatology·H Suzuki, H Ishii
Jun 18, 1997·Journal of the National Cancer Institute·R M PeekM J Blaser
Feb 13, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Temitope O KekuRobert S Sandler
May 28, 2014·Genes, Chromosomes & Cancer·Stefano GerolaMichael Neumaier
May 28, 2010·Toxicology and Industrial Health·Sevim ErcanPiraye Yargicoglu
Feb 25, 1999·The Australian and New Zealand Journal of Surgery·L M ButlerP A Cowled
Apr 14, 2000·Neurosurgery·I NgD R Smith
May 2, 2001·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·R H DashwoodD T Horio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis